EE461 Cost of Biomarker Testing Among Patients with Metastatic Lung or Thyroid Cancer in the US: A Real-World Commercial Claims Database Study

Abstract

Authors

LM Hess D Michael PM Krein T Marquart AN Sireci

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×